Charles Schwab’s Equillium EQ Stock Holding History

Charles Schwab’s Portfolio EQ Stock Details EQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,650	Closed	-$86K	–	3230
2019 Q1	$86K	Hold	10,650	–	–	﹤0.01%	3098
2018 Q4	$87K	Buy	+10,650	New	+$148K	﹤0.01%	3100

Other funds holding EQ

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab's EQ Position: Q2 2019 in Review

Charles Schwab sold out of Equillium (EQ) in Q2 2019, closing a stake of 10,650 shares — an estimated $86K sold.

Charles Schwab first reported a position in EQ in Q4 2018 and held it in 2 quarters. The position peaked at $87K in Q4 2018. 25 funds tracked by Wall St. Rank hold EQ as of Q2 2019.

Charles Schwab reported no remaining Equillium position as of Q2 2019 after selling out during the quarter.
Charles Schwab sold 10,650 Equillium shares in Q2 2019, an estimated $86K.
Charles Schwab first reported a position in Equillium in Q4 2018 and held it in 2 quarters.
Charles Schwab's Equillium position peaked at $87K in Q4 2018.
25 funds tracked by Wall St. Rank held Equillium as of Q2 2019.

Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.